During the past decade, Niercentrum aan de Amstel conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Niercentrum aan de Amstel" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "B.Braun Avitum AG" with 1 trials as a collaborator, "Dutch Kidney Foundation" with 1 trials as a collaborator and "Niercentrum aan de Amstel, Amstelveen, Netherlands" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Niercentrum aan de Amstel" are "Death" (1 trials), "Diastolic Dysfunction" (1 trials), "End Stage Renal Disease (ESRD)" (1 trials), "Heart Failure" (1 trials) and "Hemodiafiltration" (1 trials). Many other conditions were trialed in "Niercentrum aan de Amstel" in a lesser frequency.

Most popular intervention types in "Niercentrum aan de Amstel" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dapagliflozin 10 mg/day (oral)" (1 trials), "Placebo" (1 trials), "cool hemodialysis" (1 trials), "high volume hemodiafiltration" (1 trials) and "low volume hemodiafiltration" (1 trials). Other intervention names were less common.

The vast majority of trials in "Niercentrum aan de Amstel" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Niercentrum aan de Amstel". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in Niercentrum aan de Amstel, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Niercentrum aan de Amstel, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".